Doctoral Studies Sample Clauses

Doctoral Studies. 1. The official doctoral studies are aimed at advanced student training in research techniques and drafting, publishing and presenting an original research paper. These studies will end with the defence and approval of a doctoral thesis that incorporates original research results. 2. Official doctoral studies are organised through doctoral programmes, pursuant to Royal Decree 99/2011 and within these regulations. 3. The doctoral student's essential activity while undertaking these studies is research, although he/she will also have to develop research training activities. He/she will also form part of the supplementary training studies that the doctoral programme's Academic Commission considers necessary for drafting the doctoral thesis and that have not been acquired by the doctoral candidate previously. Chapter II. DOCTORATE STRUCTURE Section 1 of the Doctoral Commission
View Source
Doctoral Studies. Working title of the thesis: .............................................................................................................................................................
View Source
Doctoral Studies. (1) The Doctoral Candidate’s field of study enrolled at the RMIT is “XYZ”. The Doctoral Candidate has to provide the academic performances as defined in RMIT’s entry requirements to research programs (Doctor of Philosophy). Commencement Date at RMIT University: (2) The Doctoral Candidate’s field of study enrolled at the University of Vienna is “XYZ”. The Doctoral Candidate has to provide the academic performances as defined in the “Curriculum für das Doktoratsstudium der XYZ” (Mitteilungsblatt UG2002, XYZ. Stück, Nr. XYZ, vom TT.MM.JJJ, in der geltenden Fassung). Commencement Date at University of Vienna: In the event that the Doctoral Candidate enrols at one University ahead of the other, the Commencement Dates at each University may not differ by more than 6 months. (3) The tentative title of the doctoral thesis is “XYZ”. (4) The thesis is written in English and contains abstracts written in English and German. (5) The Doctoral Candidate’s supervisor at RMIT is XYZ, [Institute], [Mailing Address], [eMail]. The Doctoral Candidate’s supervisor at the University of Vienna is XYZ, [Institute], [Mailing Address], [eMail]. (6) The Doctoral Candidate undertakes his/her studies and research under the joint responsibility of his/her supervisors. Both supervisors commit themselves to fully exercise their competences and duties as supervisors, as defined by the regulations in force at their respective university. Both supervisors consult regularly on the research progress of the Doctoral Candidate. (7) The Doctoral Candidates annual progress at University of Vienna will be monitored and reported according to the University of Vienna’s procedures. Copies of annual progress reports will be forwarded to RMIT’s School of Graduate Research in a timely manner. (8) The Doctoral Candidate will conduct research at both universities involved in this agreement on an alternate basis. Time spent at one of the universities cannot be less than twelve months of the total research programme time defined in §7(2). The time to be allocated at each university will require the approval of the advisors. Proposed Dates of attendance at University of Vienna: Proposed Dates of attendance at RMIT:
View Source
Doctoral Studies. Chapter II. Structure of the doctorate section 1 of the Doctoral Commission article
View Source
Doctoral Studies 
View SourceView Similar (5)

Related to Doctoral Studies

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in ▇▇▇▇ rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement or the Prospectus, or the results of which are referred to in the Registration Statement or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMA, Health Canada and other comparable regulatory agencies outside of the U.S. to which they are subject, including, without limitation, 21 C.F.R. Parts 50, 54, 56, 58, 312, and 812; the descriptions of the results of such studies, tests and trials contained in the Registration Statement or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Registration Statement or the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Trials The Ship shall run the following test and trials: (1) Harbour Acceptance Tests, including setting to work of the various equipment;

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.